Focal superior quadrant haemorrhages in post COVID-19 patient: A target for personalized medicine

Maria Cristina Savastano, Carola Culiersi, Alfonso Savastano, Gloria Gambini, Tomaso Caporossi, Stanislao Rizzo

Research output: Contribution to journalArticle

Abstract

Purpose: To report a case of multiple superior quadrant intraretinal haemorrhages in post-COVID-19 patient. Case description: A 58-year-old male with a history of coronary artery disease and hypertension, presented with multiple superior quadrant intraretinal haemorrhages in the superonasal quadrant of the left eye 1 month after hospitalization for COVID-19. The right eye was normal. During his 10-day stay, he was treated with hydroxychloroquine, lopinavir + ritonavir, ceftriaxone, and his pre-existing antiplatelet therapy. During hospitalization, a complete medical work up showed an anomalous increase in D-dimer. He did not require intensive care support. Conclusions: In this report, we focused on the origin of retinal bleeding in a post COVID-19 patient, likely due to a focal occlusion of a vessel. Considering the nature of SARS-CoV-2 infection, we hypothesize that retinal haemorrhages were caused by a combination of factors including the patient’s antiplatelet therapy and the thrombotic microvascular injury caused by the virus.
Original languageEnglish
Pages (from-to)11206721211021296-N/A
JournalEuropean Journal of Ophthalmology
DOIs
Publication statusPublished - 2021

Keywords

  • Antiplatelet therapy
  • COVID-19
  • arterial occlusion
  • coagulopathy
  • sub-internal limiting membrane haemorrhage

Fingerprint

Dive into the research topics of 'Focal superior quadrant haemorrhages in post COVID-19 patient: A target for personalized medicine'. Together they form a unique fingerprint.

Cite this